EQT Valuation Multiples

Discover EQT's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Banco BTG Pactual, Power Corporation of Canada, Prudential, 3i Group and more.

EQT Overview

About EQT

Swedish conglomerate Investor AB set up EQT as its private equity division in 1994. In its early days, EQT focused primarily on private equity investments in Sweden and the rest of Scandinavia. Today, EQT is one of the largest global private-market investors, with funds that focus on private equity, real estate, and infrastructure globally. Investor AB retains a minority stake.


Founded

1994

HQ

Sweden

Employees

1.9K

Financials (LTM)

Revenue: $3.3B
EBITDA: $1.9B

EV

$34B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

EQT Financials

EQT reported last 12-month revenue of $3.3B and EBITDA of $1.9B.

In the same LTM period, EQT generated $3.3B in gross profit, $1.9B in EBITDA, and $1.1B in net income.

Revenue (LTM)


EQT P&L

In the most recent fiscal year, EQT reported revenue of $3.2B and EBITDA of $1.9B.

EQT is profitable as of last fiscal year, with gross margin of 63%, EBITDA margin of 58%, and net margin of 27%.

See analyst estimates for EQT
LTMLast FY202320242025202620272028
Revenue$3.3B$3.2B$2.4B$3B$3B
Gross Profit$3.3B$2B$1.2B$2B$2B
Gross Margin100%63%51%65%67%
EBITDA$1.9B$1.9B$820M$1.6B$1.6B
EBITDA Margin59%58%34%53%53%
EBIT Margin57%57%13%33%40%
Net Profit$1.1B$854M$149M$890M$835M
Net Margin35%27%6%29%28%
Net Debt-$1.7B---

Financial data powered by Morningstar, Inc.

EQT Stock Performance

EQT has current market cap of $39B, and enterprise value of $34B.

Market Cap Evolution


EQT's stock price is $33.02.

EQT share price increased by 17.0% in the last 30 days, and decreased by 6.9% in the last year.

EQT has an EPS (earnings per share) of $0.73.

See more trading valuation data for EQT
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$34B$39B10.5%17.0%3.6%-6.9%$0.73

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

EQT Valuation Multiples

EQT trades at 10.5x EV/Revenue multiple, and 17.7x EV/EBITDA.

See NTM and 2027E valuation multiples for EQT

EV / Revenue (LTM)


EQT Financial Valuation Multiples

As of July 18, 2026, EQT has market cap of $39B and EV of $34B.

EQT has a P/E ratio of 33.8x.

LTMLast FY202320242025202620272028
EV/Revenue10.5x10.7x14.3x11.2x11.3x
EV/EBITDA17.7x18.3x41.7x21.4x21.4x
EV/EBIT18.5x18.7x108.5x33.6x28.4x
EV/Gross Profit10.5x17.0x28.1x17.3x17.0x
P/E33.8x45.2xn/m43.4x46.3x
EV/FCF21.0x29.4x32.4x66.8x75.4x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified EQT Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

EQT Margins & Growth Rates

EQT grew revenue by 3% and EBITDA by 7% in the last fiscal year.

In the most recent fiscal year, EQT reported gross margin of 63%, EBITDA margin of 58%, and net margin of 27%.

See estimated margins and future growth rates for EQT

EQT Margins

Last FY202420252026202720282029
Gross Margin63%65%67%100%
EBITDA Margin58%53%53%60%
EBIT Margin57%33%40%57%
Net Margin27%29%28%42%
FCF Margin36%17%15%61%

EQT Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth3%27%(1%)9%
Gross Profit Growth64%62%2%64%
EBITDA Growth7%95%(0%)25%
EBIT Growth2%223%18%55%
Net Profit Growth62%498%(6%)66%
FCF Growth73%(52%)(11%)343%

Data powered by FactSet, Inc. and Morningstar, Inc.

EQT Operational KPIs

EQT's revenue per employee in the last FY averaged $1.7M, while opex per employee averaged $0.8M for the same period.

EQT's Rule of 40 is 70% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

EQT's Rule of X is 83% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for EQT
LTMLast FY202320242025202620272028
Rule of 4080%70%---
Bessemer Rule of X110%83%---
Revenue per Employee-$1.7M---
Opex per Employee-$0.8M---
G&A Expenses to Revenue-8%4%8%8%
Opex to Revenue44%46%38%31%27%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

EQT Competitors

EQT competitors include Banco BTG Pactual, Power Corporation of Canada, Prudential, 3i Group, ORIX, Strategy, Northern Trust, Swiss Life, Raymond James and Sun Life.

Most EQT public comparables operate across PE & VC and Asset Management.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Banco BTG Pactual5.0x7.0x--
Power Corporation of Canada2.0x3.7x--
Prudential1.1x1.2x7.9x8.1x
3i Group5.1x5.3x5.9x5.8x
ORIX3.9x3.8x30.0x28.7x
Strategy103.6x101.3x1051.9x(7.4x)
Northern Trust5.8x5.4x--
Swiss Life1.5x1.5x--

This data is available for Pro users. Sign up to see all EQT competitors and their valuation data.

Start Free Trial

Acquisitions by EQT

EQT has acquired 177 companies to date.

Last acquisition by EQT was on July 8th 2026. EQT acquired Copia Power for $2.6B (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by EQT

Copia Power
Corza Biosurgery
Orikan
Intertek
Description
Copia Power is a New York-headquartered developer of renewable energy projects across the United States. It builds solar farms and battery storage facilities totaling over 15 GW in pipeline capacity. Backed by Carlyle Group, the firm targets grid-scale assets to support decarbonization in utilities and commercial sectors. Projects operate in states like Texas and California.
Corza Biosurgery is a medical products business centered on biologic patches used in surgical hemostasis and tissue sealing.
Orikan is a technology company that supplies software and hardware systems to government agencies, hospitals, and universities.
Intertek is one of the largest and oldest companies in the testing, inspection, and certification industry. Its primary activities include testing products and materials, inspecting sites/industrial equipment, and certifying products and systems to ensure compliance with global/company standards. Intertek is one of only three TIC companies operating globally across multiple industries. The firm was listed in 2002 following Charterhouse's divestment. It employs over 40,000 people worldwide.
HQ CountryUnited StatesAustriaCanadaUnited Kingdom
HQ City
Washington, DC
Linz
Victoria
London
Deal Date8 Jul 20266 Jul 20265 Jul 202617 Jun 2026
Valuation$2.6Bundisclosed$330M$12B
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all EQT acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by EQT

EQT has invested in 121 companies to date.

Latest investment by EQT was on June 16th 2026. EQT invested in Odyssey in their $310M Series B round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by EQT

Odyssey
Vinted
Pulnovo Medical
Kelda
Description
Odyssey is a company that creates multi-agent simulation frameworks for real-time interaction between human and artificial intelligence participants. These systems rely on reinforcement learning to test game environments and surface edge cases. Organizations apply the simulations to workforce training, defense scenarios, robotics development, and adaptive entertainment systems.
Vilnius-headquartered Vinted runs a peer-to-peer online marketplace for second-hand fashion, active in 20 countries across Europe and the United States. The platform facilitates buying, selling, and swapping clothing, accessories, and shoes for women, men, and children via mobile apps with chat and bundle discounts. Valued at over 4 billion euros, Vinted processes tens of millions of listings monthly and partners with payment providers like PayPal for secure transactions.
Pulnovo Medical is a Chinese medtech firm pioneering radiofrequency ablation catheters for pulmonary hypertension treatment. Its flagship DragonFly system received China NMPA approval in 2021 and CE Mark for European markets. Established in 2013 and headquartered in Wuxi, Jiangsu Province, the company holds global patents for its endovascular RF technology and expands into atrial fibrillation ablation devices.
Kelda is a holding company owning Yorkshire Water, which provides water and sewerage services to 5.4 million customers in Yorkshire and the Humber region of northern England. Yorkshire Water collects revenue from customer charges for water delivery, wastewater treatment, and infrastructure maintenance under Ofwat regulation. Headquartered in Bradford, Kelda has remained private since its 2006 delisting, backed by investors including the Ontario Teachers' Pension Plan.
HQ CountryUnited StatesLithuaniaChinaUnited Kingdom
HQ City
San Francisco, CA
Vilnius
Wuxi
Bradford
Deal Date16 Jun 202626 Apr 202619 Apr 202610 Mar 2026
RoundSeries BSecondarySeries DUndisclosed stage
Raised$310M$1B$100Mundisclosed
InvestorsEQT; Qasar Younis; GV; Amazon; Garry Tan; Kyle Vogt; Guillermo Rauch; AMD Ventures; Natural Capital; Jeff Dean; Elad Gil; IQTEQT; BlackRock; Schroders Capital; Teachers’ Venture Growth; Lombard Odier Investment Managers; Pinegrove Opportunity PartnersEQT; Medtronic; Gaorong Capital; Qiming Venture Partners; Lilly Asia Ventures; OrbiMed; HSGEQT
Valuation$1.4B$9.3Bundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all EQT investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About EQT

When was EQT founded?EQT was founded in 1994.
Where is EQT headquartered?EQT is headquartered in Sweden.
How many employees does EQT have?As of today, EQT has over 1K employees.
Who is the CEO of EQT?EQT's CEO is Christian Sinding.
Is EQT publicly listed?Yes, EQT is a public company listed on Nasdaq Stockholm.
What is the stock symbol of EQT?EQT trades under EQT ticker.
When did EQT go public?EQT went public in 2019.
Who are competitors of EQT?EQT main competitors include Banco BTG Pactual, Power Corporation of Canada, Prudential, 3i Group, ORIX, Strategy, Northern Trust, Swiss Life, Raymond James, Sun Life.
What is the current market cap of EQT?EQT's current market cap is $39B.
What is the current revenue of EQT?EQT's last 12 months revenue is $3.3B.
What is the current revenue growth of EQT?EQT revenue growth (NTM/LTM) is 20%.
What is the current EV/Revenue multiple of EQT?Current revenue multiple of EQT is 10.5x.
What is the current EBITDA of EQT?EQT's last 12 months EBITDA is $1.9B.
What is EQT's EBITDA margin?EQT's last 12 months EBITDA margin is 59%.
What is the current EV/EBITDA multiple of EQT?Current EBITDA multiple of EQT is 17.7x.
What is the current FCF of EQT?EQT's last 12 months FCF is $1.6B.
What is EQT's FCF margin?EQT's last 12 months FCF margin is 50%.
What is the current EV/FCF multiple of EQT?Current FCF multiple of EQT is 21.0x.
How many companies EQT has acquired to date?As of July 2026, EQT has acquired 176 companies.
What was the largest acquisition by EQT?$14B acquisition of Zayo on 9th March 2020 was the largest M&A EQT has done to date.
What companies EQT acquired?EQT acquired Zayo, Intertek, Galderma, PAREXEL, BPEA EQT, Urbaser, Dechra Pharmaceuticals, Fortnox, Reworld Holding Corporation, Calisen, and 166 other companies.
In how many companies EQT has invested to date?As of July 2026, EQT has invested in 121 companies.
What was the last EQT investment?On 16th June 2026 EQT invested in Odyssey, participating in a $310M Series B round at $1.4B valuation, alongside Qasar Younis, GV, Amazon, Garry Tan, Kyle Vogt, Guillermo Rauch, AMD Ventures, Natural Capital, Jeff Dean, Elad Gil, and 1 other investor.
In what companies EQT invested in?EQT invested in IVC Evidensia, Sitecore, Vinted, Mollie, Wolt, O2 Power, ReliaQuest, Epidemic Sound, ManyPets, Lovable, Odyssey, Mews, Mambu, Cirba Solutions, Perk, Electra Therapeutics, Arvelle Therapeutics, Noema Pharma, VectorY, Tubulis, and 101 other companies.

See public comps similar to EQT

Lists including EQT

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial